EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa

Jennifer Geel iD, Anel van Zyl iD, Jan du Plessis iD, Marc Hendricks iD, Yasmin Goga iD, Amy Carr iD, Beverley Neethling iD, Artsiom Hramyka iD, Fareed Omar iD, Rema Mathew iD, Lizette Louw iD, Thanushree Naidoo und 8 weitere

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.30712 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Jennifer Geel und 19 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Haematology-Oncology, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Wits Donald Gordon Medical Centre, …. Hauptthemen laut MEDLINE: Hodgkin Disease, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Carnegie Corporation Research Funding, Wits Faculty Research Committee, Crowdfunding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Historic South African 5‐year overall survival (OS) rates for Hodgkin lymphoma (HL) from 2000 to 2010 were 46% and 84% for human immunodeficiency virus (HIV)‐positive and HIV‐negative children, respectively. We investigated whether a harmonised treatment protocol using risk stratification and response‐adapted therapy could increase the OS of childhood and adolescent HL.

Methods

Seventeen units prospectively enrolled patients less than 18 years, newly diagnosed with classical HL onto a risk‐stratified, response‐adapted treatment protocol from July 2016 to December 2022. Low‐ and intermediate‐risk patients received four and six courses of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD), respectively. High‐risk patients received two courses of ABVD, followed by four courses of cyclophosphamide, vincristine, prednisone, and dacarbazine (COPDac). Those with a slow early response and bulky disease received consolidation radiotherapy. HIV‐positive patients could receive granulocyte colony‐stimulating factor and less intensive therapy if stratified as high risk, at the treating clinician's discretion. Kaplan–Meier survival analysis was performed to determine 2‐year OS and Cox regression to elucidate prognostic factors.

Results

The cohort comprised 132 patients (19 HIV‐positive, 113 HIV‐negative), median age of 9.7 years, with a median follow‐up of 2.2 years. Risk grouping comprised nine (7%) low risk, 36 (27%) intermediate risk and 87 (66%) high risk, with 71 (54%) rapid early responders and 45 (34%) slow early responders, and 16 (12%) undocumented. Two‐year OS was 100% for low‐risk, 93% for intermediate‐risk, and 91% for high‐risk patients. OS for HIV‐negative (93%) and HIV‐positive (89%) patients were similar ( p = .53). Absolute lymphocyte count greater than 0.6 × 10 9 predicted survival (94% vs. 83%, p = .02).

Conclusion

In the first South African harmonised HL treatment protocol, risk stratification correlated with prognosis. Two‐year OS of HIV‐positive and HIV‐negative patients improved since 2010, partially ascribed to standardised treatment and increased supportive care. This improved survival strengthens the harmonisation movement and gives hope that South Africa will achieve the WHO Global Initiative for Childhood Cancer goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseHIV InfectionsHumansChildAdolescentSouth AfricaDacarbazineVinblastineBleomycinDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsPrednisoneVincristine

Stichwörter der Autor:innen

GICCHodgkin lymphomaSouth Africaadolescentchildharmonisation

Substanzen

DacarbazineVinblastineBleomycinDoxorubicinPrednisoneVincristine

Autor:innen und Institutionen

  • Pediatric Haematology-Oncology, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
  • Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa.
  • Pediatric Haematology-Oncology, University of the Free State, Universitas Hospital, Bloemfontein, South Africa.
  • Department of Paediatrics and Child Health, Haematology-Oncology Service, Faculty of Health Sciences, University of Cape Town, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
  • Pediatric Haematology-Oncology, University of KwaZulu-Natal Durban, Greys Hospital, Pietermaritzburg, South Africa.
  • Pediatric Haematology-Oncology, University of KwaZulu-Natal Durban, Inkosi Albert Luthuli Hospital and Greys Hospital, Pietermaritzburg, South Africa.

ORCID-Profile: Jennifer Geel, Anel van Zyl, Jan du Plessis, Marc Hendricks, Yasmin Goga, Amy Carr, Beverley Neethling, Artsiom Hramyka, Fareed Omar, Rema Mathew, Lizette Louw, Thandeka Ngcana, Tanya Schickerling, Vutshilo Netshituni, Liezl du Plessis, Tom Kelsey, Daynia E Ballot, Monika L Metzger

Förderung

  • Carnegie Corporation Research Funding
  • Wits Faculty Research Committee
  • Crowdfunding
  • Doit4Charity
  • Ride Joburg Cycle Race

Zitieren

APA

Geel, J., van Zyl, A., Plessis, J. D., Hendricks, M., Goga, Y., Carr, A., Neethling, B., Hramyka, A., Omar, F., Mathew, R., Louw, L., Naidoo, T., Ngcana, T., Schickerling, T., Netshituni, V., Madzhia, E., du Plessis, L., Kelsey, T., Ballot, D. E., & Metzger, M. L. (2024). Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30712

Vancouver

Geel J, van Zyl A, Plessis JD, Hendricks M, Goga Y, Carr A, et al. Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30712

BibTeX
@article{Geel2024,
  author = {Geel, Jennifer and van Zyl, Anel and Plessis, Jan du and Hendricks, Marc and Goga, Yasmin and Carr, Amy and Neethling, Beverley and Hramyka, Artsiom and Omar, Fareed and Mathew, Rema and Louw, Lizette and Naidoo, Thanushree and Ngcana, Thandeka and Schickerling, Tanya and Netshituni, Vutshilo and Madzhia, Elelwani and du Plessis, Liezl and Kelsey, Tom and Ballot, Daynia E and Metzger, Monika L},
  title = {Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.30712}
}
Kostenlos starten →